Update related to Trilogy Evo platform of ventilators

Some Trilogy 100/200  and V60/V60 Plus users impacted by Philips Respironics recalls may be using the Trilogy Evo platform of ventilators as an alternative. Please  be aware of recent important product updates related to the Trilogy Evo platform of devices. Please note, when the mitigating actions specified in the Field Safety Notices are taken:

 

• Trilogy Evo continues to be an alternative for Trilogy 100 and Trilogy 200 devices impacted by the June 2021 recall of certain CPAP, BiPAP and mechanical ventilators related to PE-PUR sound abatement foam
• The Trilogy EV300 continues to be an alternative for Philips Respironics V60 and V60 Plus devices impacted by an issue related to the power management PC board

For more information on the software available to address some issues presented within previous field safety notices, please click here. 

For information on the Trilogy Evo Platform Flow Sensor Nebulized Aerosol Deposition Medical Device Correction 2024-CC-SRC-013, please click here.